Michael S. Weiss - 05 Nov 2025 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
CEO, Director
Signature
/s/ Michael S. Weiss
Issuer symbol
TGTX
Transactions as of
05 Nov 2025
Net transactions value
$0
Form type
4
Filing time
07 Nov 2025, 17:01:49 UTC
Previous filing
30 May 2025
Next filing
09 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Michael S. Weiss filed Form 4 for TG THERAPEUTICS, INC. (TGTX) on 07 Nov 2025."

Quick Takeaways

  • This page summarizes Michael S. Weiss's Form 4 filing for TG THERAPEUTICS, INC. (TGTX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 07 Nov 2025, 17:01.

What Changed

  • Previous filing in this sequence was filed on 30 May 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WEISS MICHAEL S CEO, Director 3020 CARRINGTON MILL BLVD, SUITE 475, MORRISVILLE /s/ Michael S. Weiss 07 Nov 2025 0001038977

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX Common Stock Gift $0 -3,865,126 -28% $0.000000 9,959,803 05 Nov 2025 Direct F1, F2
transaction TGTX Common Stock Gift $0 -803,717 -8.1% $0.000000 9,156,086 05 Nov 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents distribution of shares upon termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of Mr. Weiss' children.
F2 Includes shares of restricted Common Stock, which vest over various time periods.
F3 Represents the transfer of shares to The Weiss Family and Descendants Trust.

Sponsored